Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

AbbVie Inc. (ABBV) Profit Margins

Over the twelve months to 2026-06-30, AbbVie Inc. (ABBV) had gross margin 71.5%, operating margin 26.2%, net margin 9.8%, free cash flow margin 28.3%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ABBVAbbVie Inc.Follow ABBV — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
504.8B
P/E TTM
80.7
Dividend yield
2.4%
52-week
—
Next earnings
30 Oct, in 6 days
LineFY2013
Dec 13
FY2014
Dec 14
FY2015
Dec 15
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin75.6%77.8%80.3%77.2%75.0%76.4%77.6%66.4%69.0%70.0%62.4%70.0%70.2%71.5%
Operating margin30.1%17.1%33.0%36.4%33.8%19.5%39.0%24.8%31.9%31.2%23.5%16.2%24.6%26.2%
Net margin22.0%8.8%22.4%23.2%18.8%17.4%23.7%10.1%20.5%20.4%9.0%7.6%6.9%9.8%
FCF margin30.7%14.7%30.6%25.6%33.4%39.0%38.4%36.7%39.1%41.8%40.6%31.7%29.1%28.3%

USD billions · SEC XBRL

AbbVie Inc. — questions

What is AbbVie Inc.'s gross margin?
71.5% over the twelve months to 2026-06-30.
What is AbbVie Inc.'s operating margin?
26.2% over the twelve months to 2026-06-30.
What is AbbVie Inc.'s net profit margin?
9.8% over the twelve months to 2026-06-30.

Every figure on this page comes from AbbVie Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.